A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)-Reference-Cited by-同舟云学术

A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)

Published:2008-05-24 Issue:11 Volume:18 Page:1430-1437
ISSN:0960-8923
Container-title:Obesity Surgery
language:en
Short-container-title:OBES SURG

Author:

Younossi Zobair M.,Jarrar Mohammed,Nugent Clare,Randhawa Manpreet,Afendy Mariam,Stepanova Maria,Rafiq Nila,Goodman Zachary,Chandhoke Vikas,Baranova Ancha

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11695-008-9506-y.pdf

Reference32 articles.

1. Ong J, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in obese patients. Obes Surg. 2005;15(3):310–5.

2. Mulhall BP, Younossi ZM. Nonalcoholic steatohepatitis. Curr Treat Options Gastroenterol. 2004;7:423–30.

3. Marchesini G, Bugianesi E, Forlani G, Marzocchi R, Zannoni C, Vanni E, et al. Non-alcoholic steatohepatitis in patients cared in metabolic units. Diabetes Res Clin Pract. 2004;63:143–51.

4. Younossi ZM, McCullough AJ, Ong JP, Barnes DS, Post A, Tavill A, et al. Obesity and non-alcoholic fatty liver disease in chronic hepatitis C. J Clin Gastroenterol. 2004;38:705–9.

5. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32:477–81.

Cited by 235 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine learning-based model analysis for serum markers of liver fibrosis in chronic hepatitis B patients;Scientific Reports;2024-05-27

2. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease;Metabolites;2023-10-29

3. The Value of Serologic Markers/Scores in the Assessment of Nonalcoholic Fatty Liver Disease;Essentials of Non-Alcoholic Fatty Liver Disease;2023

4. Concurrent HCV or fatty liver in patients with chronic hepatitis B virus infection;Comprehensive Guide to Hepatitis Advances;2023

5. Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis;Minerva Medica;2022-12